skip to main content

    Updated Visitor Guidelines

 

MENU

 

Illuminate and Research News Communications

Sign-up to receive Illuminate and/or Advancing Cancer in your inbox.

Illuminate showcases the important and unique research underway at the Rogel Cancer Center, while Advancing Cancer highlights advances in clinical care.

Rogel Cancer Center attends ASCO's annual meeting

Rogel Cancer Center faculty and trainees will lead two dozen presentations, posters and moderated sessions at the American Society for Clinical Oncology annual meeting. This year’s meeting will be held in-person and online. View the schedule of presentations and poster sessions.

Experts discuss advances in thyroid cancer diagnosis and treatment

After years in the shadow of more common cancers, there’s new light for patients with thyroid cancer. Increased use of neck ultrasounds has driven up the number of people globally who are diagnosed with thyroid cancer, which has brought new attention to the disease. It’s now the ninth most common cancer worldwide.

Researchers discover cancer cells use a new fuel in absence of sugar

Researchers at the University of Michigan Rogel Cancer Center have discovered a new nutrient source that pancreatic cancer cells use to grow. The molecule, uridine, offers insight into both biochemical processes and possible therapeutic pathways.

Combatting critical drug shortages

Andrew Shuman, M.D., FACS, HEC-C, chief of the clinical ethics service in Michigan Medicine’s Center for Bioethics and Social Sciences, recently testified before the Homeland Security and Governmental Affairs Committee for the United States Senate regarding critical drug shortages.

Researchers learn saturated fatty acids promote immune escape of oral cancers

A team from the University of Michigan Rogel Cancer Center and School of Dentistry, led by Yu Leo Lei, D.D.S., Ph.D., have identified a mechanism in mice for how obesity affects some oral cancers’ ability to escape from the immune system.

Researchers study the connection between density of nerves within a tumor and the tumor's growth

Researchers at the U-M Rogel Cancer Center created a standardized metric for nerve density to clarify the variation in distribution of nerves in the oral cavity, called normalized nerve density, and showed its importance in oral cancer tumor progression.

Lee receives $1.4M grant from NCI to study the role of low oxygen supply in pancreatic cancer

Rogel Cancer Center researcher Kyoung Eun Lee, Ph.D., assistant professor of pharmacology at Michigan Medicine, has received a new $1.4 million grant from the National Cancer Institute to study the stroma and in particular how low oxygen conditions, or hypoxia, in pancreatic cancer alters the tumor-stroma interaction – and how to capitalize on that to target potential new treatments.

Rogel researchers receive $2M to study pancreatic cancer microenvironment

Researchers at the University of Michigan Rogel Cancer have received a $2 million grant from the National Cancer Institute to understand the role myeloid cells play in how pancreatic cancer develops and progresses.

Rich Nelson, J.D.

Rich has more than 25 years of experience in mergers and acquisitions. He currently is executive vice president of corporate development at Vericast, a marketing services company where he is responsible for the identification and execution of global merger and acquisition opportunities. He is also executive vice president of corporate development and a board member of vTv Therapeutics, a clinical pharmaceutical company that has received breakthrough designation from the FDA for its Type 1 Diabetes drug.

Pages